Investigators compared the efficacy of Er:YAG plus long-pulsed Nd:YAG combination laser therapy with Er:YAG laser alone after 1 session in patients with recalcitrant warts.

Investigators sought to assess treatment patterns and medication utilization in the first year following vitiligo diagnosis.

Researchers examined the prevalence and predictors of coronary microvascular dysfunction in patients with psoriasis without cardiovascular disease.

Researchers reviewed treatment patterns in adults with alopecia areata.

A phase 3 trial evaluating rolfumilast cream 0.05% in children with mild to moderate atopic dermatitis met its primary and all secondary endpoints.

A report confirmed the association between herpes zoster ophthalmicus and increased stroke risk.

Researchers assessed whether an AI-based automatic bronchial segment identification system offering feedback improves the performance of novice bronchoscopists.

Researchers examined rates of hospital-acquired COVID-19 infection across different periods of the pandemic.

In a systematic review, researchers evaluated the efficacy and safety of topical azelaic acid as a treatment for acne vulgaris, rosacea, melasma, hyperpigmentation, and skin aging.

Researchers evaluated racial and ethnic differences in disease severity and treatment patterns among patients with atopic dermatitis in an urban setting.

Researchers examined the occurrence of long-term symptoms after omicron infection compared with other COVID-19 variants.

Researchers examined trends in invasive pneumococcal infection in children with sickle cell disease.

Brodalumab may reduce symptoms of psoriasis, depression, and anxiety in patients with generalized pustular psoriasis.

Investigators aimed to create and validate a risk prediction model for estimating the development of psoriatic arthritis among patients with psoriasis.

Investigators assessed how the outcomes of patients with psoriatic arthritis may be improved using lifestyle modifications and nonpharmacologic and psychologic interventions.

Investigators evaluated the association between psoriasis and the occurrence of retinal
vein occlusion in those with a diabetic retinopathy diagnosis.

Researchers evaluated the incidence, characteristics, and long-term outcomes of chronic immune-related adverse events resulting from adjuvant anti-PD-1 therapy in patients with resected high-risk melanoma.

Researchers sought to identify specific risk factors for developing subsequent primary melanoma.

Researchers estimated the association between receipt of the wild-type BNT162b2 vaccine and medically attended COVID-19 outcomes among children younger than 5 years.

California is on track to become the first state to ban 4 food additives that some experts have linked to health issues.

Investigators assessed the prevalence of psoriasis in self-reported questionnaires vs confirmed physician diagnoses among patients with axial spondyloarthritis.

Investigators explored the views and practices of rheumatologists and dermatologists regarding psoriatic arthritis screening, diagnosis, and care.

Investigators conducted an overview of reviews assessing interventions designed to prevent physician burnout among rheumatologists.

Researchers examined the global burden of cardiovascular diseases attributable to particulate matter pollution from 1990 to 2019.

In a 2-part phase 3 study, investigators evaluated the efficacy and safety of nemolizumab administered concomitantly with topical agents in Japanese pediatric patients with atopic dermatitis and poorly controlled moderate to severe pruritis.

Researchers aimed to quantify the lifetime burden of Stevens-Johnson syndrome/ toxic epidermal necrolysis.

Researchers assessed the epidemiologic and clinical characteristics of mpox in individuals with past infection or vaccination in a global case series.

Researchers examined ChatGPT capacity to generate opinions on vaccine hesitancy.

Skin transcriptomes may be useful in identifying patients with systemic sclerosis at risk of developing interstitial lung disease.

Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna have now been approved and authorized for emergency use.